Data, Digitization and Disruption
White Paper
Sep 30, 2019
Biopharma confronts the innovator's dilemma

Over the last decade a series of market and technological changes has challenged biopharma companies to reimagine how they engage with key customers – and even to reconsider which customers are most important. As physicians increasingly share their central role in treatment decisions with other, often institutional stakeholders, manufacturers' traditional commercial model risks diminishing returns. The treatment decision-making process is shifting as rapid digitization amplifies the explosion of healthcare data sources and information. While the personalization of treatment strategies shows tantalizing promise, it rests upon the integration of multiple sources of information, drawn from multiple stakeholders, to provide tailored, precise treatments. Companies must envision a different model, designed to work across a more complex, multi-stakeholder landscape, in which their own role must evolve.

Contact Us
Contact Us

Email Us

Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?

Call Us

We're available during standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.